Thermo Fisher Scientific expands its cell therapy development and manufacturing capabilities with new facility in San Francisco, CA.
The path for long-term success of small biopharmaceutical companies are often in the hands of the consultant. Today consultants are faced with the challenge of choosing from multiple paths between different CDMO partners. Choosing the path with the right CDMO partner can ensure the success and advancement of the molecule leading to where you desire your biopharma clients to be.
Learn which CDMO partner can lead your biopharma clients down the ideal path and keep client’s projects on time, and on track for regulatory and market success.